Posttreatment but Not Pretreatment with Selective β-Adrenoreceptor 1 Antagonists Provides Neuroprotection in the Hippocampus in Rats Subjected to Transient Forebrain Ischemia
Authors:
- Satoki InoueSISatoki Inoue
- Masahiko KawaguchiMKMasahiko Kawaguchi
- Mitsutoshi NakamuraMNMitsutoshi Nakamura
- Noboru KonishiNKNoboru Konishi
- Hitoshi FuruyaHFHitoshi Furuya
- 1 April 2010
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 110 (4) , 1126-1132
Abstract
Not been examined. Therefore, we investigated the neuroprotective effects of preischemic or postischemic administration of propranolol (a nonselective β-adrenoreceptor antagonist), esmolol, and landiolol (selective β-adrenoreceptor 1 antagonists) against forebrain ischemia in rats. METHODS: IV administration of saline 10 μL · h−1, propranolol 100 μg · kg−1 · min−1, esmolol 200 μg · kg−1 · min−1, or landiolol 50 μg · kg−1 · min−1 in male Sprague-Dawley rats was started 30 minutes before or 60 minutes after 8-minute bilateral carotid artery occlusion combined with hypotension (35 mm Hg) under isoflurane (1.5%) anesthesia. All drugs were administered continuously until 5 days after reperfusion, and the animals were evaluated neurologically and histologically after this 5-day period. RESULTS: Preischemic treatment with propranolol, esmolol, or landiolol failed to provide neuroprotection against forebrain ischemia in the hippocampus. Rats treated with propranolol tended to have a worse score for motor activity and a higher mortality rate (up to 64%), but the differences with other groups were not statistically significant. Postischemic treatment with esmolol and landiolol, but not with propranolol, reduced neuronal injury after forebrain ischemia. However, motor activity did not differ among rats treated postischemically with any of the β-adrenoreceptor antagonists or saline. CONCLUSIONS: Postischemic treatment with esmolol and landiolol provided neuroprotection in the hippocampus in rats subjected to bilateral carotid artery occlusion combined with hemorrhagic shock, whereas treatment with propranolol failed to show neuroprotection. We suggest that concomitant β-blockade and shock might work as a systemic depressant, rather than a neuroprotectant, resulting in exacerbation of cerebral ischemia....Keywords
This publication has 25 references indexed in Scilit:
- The effects of perioperative β-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trialAmerican Heart Journal, 2006
- ??-Adrenoreceptor Antagonists Attenuate Brain Injury After Transient Focal Ischemia in RatsAnesthesia & Analgesia, 2006
- The diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgeryAmerican Heart Journal, 2004
- Development of a Highly Cardioselective Ultra Short-Acting .BETA.-Blocker, ONO-1101.Chemical and Pharmaceutical Bulletin, 1992
- Rodent models of cerebral ischemia.Stroke, 1989
- Treatment of Acute Focal Cerebral Ischemia and Recirculation with d-PropranololNeurosurgery, 1985
- Treatment of acute focal cerebral ischemia with propranolol.Stroke, 1984
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Treatment of acute focal cerebral ischemia with propranolol.Stroke, 1982
- Potential biochemical mechanisms for regulation of the slow inward current: Theoretical basis for drug actionAmerican Heart Journal, 1982